5546144
Tocris Bioscience™ CCG 1423
Induces intermediate mesoderm differentiation from ESCs; Rho/SRF pathway inhibitor
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Purity
>99%
Product Type
CCG 1423
Molecular Weight (g/mol)
454.75
Inhibitors
Rho GTPase Inhibitors
Related Products
Description
- Rho/SRF pathway inhibitor; stimulates apoptosis of a melanoma cell line overexpressing RhoC (A375M2)
- Suppresses Rho-dependent invasion of PC-3 prostate cancer cells in vitro and inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells
- When used in combination with Retinoic acid, LY 294002 and Pyridone 6, it induces intermediate mesoderm differentiation from ESCs.
Compare Similar Items
Show Difference
Purity: >99%
Product Type: CCG 1423
Molecular Weight (g/mol): 454.75
Inhibitors: Rho GTPase Inhibitors
Purity:
>99%
Product Type:
CCG 1423
Molecular Weight (g/mol):
454.75
Inhibitors:
Rho GTPase Inhibitors
Purity: >98%
Product Type: CE3F4
Molecular Weight (g/mol): 351.01
Inhibitors: EPAC Inhibitors
Purity:
>98%
Product Type:
CE3F4
Molecular Weight (g/mol):
351.01
Inhibitors:
EPAC Inhibitors
Purity: >99%
Product Type: CKI 7 dihydrochloride
Molecular Weight (g/mol): 358.67
Inhibitors: CKI 7 dihydrochloride
Purity:
>99%
Product Type:
CKI 7 dihydrochloride
Molecular Weight (g/mol):
358.67
Inhibitors:
CKI 7 dihydrochloride
Purity: >99%
Product Type: D-Luciferin sodium salt
Molecular Weight (g/mol): 302.3
Inhibitors: D-Luciferin sodium salt
Purity:
>99%
Product Type:
D-Luciferin sodium salt
Molecular Weight (g/mol):
302.3
Inhibitors:
D-Luciferin sodium salt